Showing results (1841-1850 of 2,203) with videos related to

Sort By:
Pageof 221
Arthritis and Rheumatism|September 29, 2011
Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugsRoy Fleischmann, Maurizio Cutolo, Mark C Genovese, et al.
The New England Journal of Medicine|June 19, 2014
Tofacitinib versus methotrexate in rheumatoid arthritisEun Bong Lee, Roy Fleischmann, Stephen Hall, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
PTMOverlay: A Proteomic Tool to Visualize Post-Translational Modifications Across EvolutionCamille Krieger, Zachary Everton, Youngki You, et al.
Angewandte Chemie (International Ed. in English)|November 4, 2023
Isolation and Characterization of Monomeric Human RAD51: A Novel Tool for Investigating Homologous Recombination in CancerFrancesco Rinaldi, Fabrizio Schipani, Beatrice Balboni, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 3, 2010
Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trialCharles H Kellner, Rebecca Knapp, Mustafa M Husain, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Development of Computational Pipeline for Right Ventricular Hemodynamic Single-Beat AnalysisGyeongtae S Moon, Paul J Scheel, Maggie Montovano, et al.
Lancet (London, England)|January 9, 2013
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trialGerd R Burmester, Ricardo Blanco, Christina Charles-Schoeman, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|December 14, 2012
Functionalization of monodisperse iron oxide NPs and their properties as magnetically recoverable catalystsSamuel H Gage, Barry D Stein, Linda Zh Nikoshvili, et al.
Journal of the American College of Radiology : JACR|July 20, 2021
Facilitating Surveillance of Incidental Findings Using a Novel Reporting Template: Proof of Concept in Patients With Pancreatic AbnormalitiesWilliam C Smith, Gaurav Khatri, Samuel H Dunn, et al.
Plos One|May 6, 2014
Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatmentKendall C Shibuya, Vikas K Goel, Wei Xiong, et al.
Pageof 221